IMU
Click for more information
2.00% 5.1¢ imugene limited

Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-28

  1. VagrancyHD
    852 Posts.
    lightbulb Created with Sketch. 183
    clock Created with Sketch.
    16/11/21
    08:41
    Post #: 57600668
    "The study’s primary endpoint is pathologic complete response. Secondary endpoints include safety and biomarker evaluation."

    They're going in for the kill!
    IMU Price at posting: 57.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 61  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BOE Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
DVP Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.1¢ 		Change
0.001(2.00%) 		Mkt cap ! $382.1M
Open High Low Value Volume
5.1¢ 5.3¢ 5.0¢ $623.8K 12.08M

Buyers (Bids)

No. Vol. Price($)
7 347323 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.3¢ 632940 5
View Market Depth
Last trade - 16.10pm 07/08/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.